cytokine release syndrome
Large Data Set Sheds Light on Rate of CAR-T Side Effects
A new analysis may offer a reliable picture of cytokine release syndrome occurrence after CAR-T therapy.
JULY 29, 2024
FDA Approves Actemra for Treatment of CAR T-Cell–Induced CRS
Tocilizumab (Actemra, Genentech) has received an additional indication—treatment of chimeric antigen receptor ...
AUGUST 31, 2017
New CAR T-Cell Therapy Promising for Multiple Myeloma
An experimental chimeric antigen receptor T-cell therapy may be effective in treating multiple myeloma without the ...
JANUARY 5, 2017
Load more